Type I tyrosinemia involves the loss of fumarylacetoacetate hydrolase (FAH), which converts fumarylacetoacetate to fumarate and acetoacetate a few steps further downstream of the tyrosine degradation pathway. Here, FAH is linked to tyrosinemia.